Published: 29 February 2020
Author(s): C. Balla, A. Brieda, A. Righetto, F. Vitali, M. Malagù, R. Cultrera, M. Bertini
Issue: July 2020
Section: Original article

Over the past few decades, a rapid and stable increase in cardiovascular implantable electronic devices (CIEDs) rates has been observed. Continuous aging of the population and a wider spectrum of indications with an improved device manufacturing are probably the main factors of the expanding use of CIEDs [1]. However, the higher complexity of the implanted devices and the increasing prevalence of “high-risk” patients with frequent comorbidities have led to an increase in CIED-related infections [2,3].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.